Literature DB >> 11751412

Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer.

J Mollenhauer1, S Herbertz, B Helmke, G Kollender, I Krebs, J Madsen, U Holmskov, K Sorger, L Schmitt, S Wiemann, H F Otto, H J Gröne, A Poustka.   

Abstract

Deleted in Malignant Brain Tumors 1 (DMBT1) has been proposed as a candidate tumor suppressor gene for brain, lung, and digestive tract cancer. In particular, alterations of the gene and/or a loss of expression have been observed in gastric, colorectal, and esophageal carcinomas. Initial evidence has accumulated that DMBT1 may represent a multifunctional protein. Because the consequences of a loss of DMBT1 function may be different depending on its original function in a particular tissue, we wondered if it is appropriate to assume a uniform role for DMBT1 in digestive tract carcinomas. We hypothesized that a systematic characterization of DMBT1 in the human alimentary tract would be useful to improve the understanding of this molecule and its role in digestive tract carcinomas. Our data indicate that the expression pattern and subcellular distribution of DMBT1 in the human alimentary tract is reminiscent of epithelial mucins. Bovine gallbladder mucin is identified as the DMBT1 homologue in cattle. An elaborate alternative splicing may generate a great variety of DMBT1 isoforms. Monolayered epithelia display transcripts of 6 kb and larger, and generally show a lumenal secretion of DMBT1 indicating a role in mucosal protection. The esophagus is the only tissue displaying an additional smaller transcript of approximately 5 kb. The stratified squamous epithelium of the esophagus is the only epithelium showing a constitutive targeting of DMBT1 to the extracellular matrix (ECM) suggestive of a role in epithelial differentiation. Squamous cell carcinomas of the esophagus show an early loss of DMBT1 expression. In contrast, adenocarcinomas of the esophagus commonly maintain higher DMBT1 expression levels. However, presumably subsequent to a transition from the lumenal secretion to a targeting to the ECM, a loss of DMBT1 expression also takes place in adenocarcinomas. Regarding DMBT1 as a mucin-like molecule is a new perspective that is instructive for its functions and its role in cancer. We conclude that DMBT1 is likely to play a differential role in the genesis of digestive tract carcinomas. However, although DMBT1 originally has divergent functions in monolayered and multilayered epithelia, carcinogenesis possibly converges in a common pathway that requires an inactivation of its functions in the ECM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751412

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Selective gene expression by rat gastric corpus epithelium.

Authors:  M Goebel; A Stengel; N W G Lambrecht; G Sachs
Journal:  Physiol Genomics       Date:  2010-12-21       Impact factor: 3.107

2.  Detection of deleted in malignant brain tumors 1 and runt-related transcription factor 3 gene expressions in bladder carcinoma.

Authors:  Yavuz Dodurga; Cığır Biray Avcı; N Lale Satiroglu-Tufan; Canten Tataroglu; Zehra Kesen; Z Ozlem Doğan; Sunde Yılmaz; Cumhur Gündüz
Journal:  Mol Biol Rep       Date:  2011-09-29       Impact factor: 2.316

3.  Over-expression of Ephb4 is associated with carcinogenesis of gastric cancer.

Authors:  M Li; Z W Zhao; Y Zhang; Y Xin
Journal:  Dig Dis Sci       Date:  2010-08-05       Impact factor: 3.199

4.  Modeling colon adenocarcinomas in vitro a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction.

Authors:  Helmut Dolznig; Christian Rupp; Christina Puri; Christian Haslinger; Norbert Schweifer; Elisabeth Wieser; Dontscho Kerjaschki; Pilar Garin-Chesa
Journal:  Am J Pathol       Date:  2011-04-30       Impact factor: 4.307

5.  The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells.

Authors:  Thomas E Grys; Matthew B Siegel; Wyndham W Lathem; Rodney A Welch
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  The scavenger receptor, cysteine-rich domain-containing molecule gp-340 is differentially regulated in epithelial cell lines by phorbol ester.

Authors:  W Kang; O Nielsen; C Fenger; J Madsen; S Hansen; I Tornoe; P Eggleton; K B M Reid; U Holmskov
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

7.  Respiratory Deleted in Malignant Brain Tumours 1 (DMBT1) levels increase during lung maturation and infection.

Authors:  H Müller; C End; C Weiss; M Renner; A Bhandiwad; B M Helmke; N Gassler; M Hafner; A Poustka; J Mollenhauer; J Poeschl
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

8.  Expression of deleted in malignant brain tumor-1 (DMBT1) molecule in biliary epithelium is augmented in hepatolithiasis: possible participation in lithogenesis.

Authors:  Motoko Sasaki; Shiu-Feng Huang; Miin-Fu Chen; Yi-Yin Jan; Ta-Sen Yeh; Akira Ishikawa; Jan Mollenhauer; Annemarie Poustka; Koichi Tsuneyama; Yuji Nimura; Koji Oda; Yasuni Nakanuma
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

9.  First evidence of the interaction between deleted in malignant brain tumor 1 and galectin-3 in the mammalian oviduct.

Authors:  M L Roldán; P E Marini
Journal:  Histochem Cell Biol       Date:  2013-09-25       Impact factor: 4.304

10.  Elevated DMBT1 levels in neonatal gastrointestinal diseases.

Authors:  Hanna Müller; Marcus Renner; Burkhard M Helmke; Jan Mollenhauer; Ursula Felderhoff-Müser
Journal:  Histochem Cell Biol       Date:  2015-11-05       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.